Efficacy and Safety of Dienogest for Endometriosis: A Systematic Review and Meta-Analysis of Standard-Dose Treatment With Supplementary Low-Dose Evidence
Year: 2026
Type: study-registration
Abstract: This systematic review and meta-analysis evaluated the efficacy and safety of continuous dienogest (DNG) 2 mg/d for endometriosis, with supplementary evaluation of a low-dose 1 mg/d regimen. PubMed, Embase, and Web of Science were searched from database inception to October 27, 2026. Fifty-one study reports were included, of which 16 constituted the core outcome analysis set. Random-effects meta-analyses assessed lumbar spine bone mineral density (BMD) change and treatment discontinuation; pain outcomes were synthesized narratively. DNG 2 mg/d was superior to placebo for pelvic pain, with a pooled BMD change of −0.66% at approximately 24 weeks and pooled discontinuation proportions of 5.65% (adverse events) and 2.10% (bleeding). Noninferiority of DNG 1 mg/d was not confirmed.
Source: Open Science Framework
Authors: XiuHua Fan, XueMei Sun, Xin Du, YuJing Zhao
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225814590
